DEMUTH PETER (Chief Scientific Officer) received a stock award from ELICIO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/3/2026ACC: 0001601485-26-000006
Officer· Chief Scientific Officer
Since Feb 2026
+62.40K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
62.40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20.80K
Price / share
—
Trade value
—
% of position
2799.5%
2/2/2026
743.00→21.54K
Total
Net shares
+20.80K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | A · Award | +20.80K | — | — | 2799.5% | 743.00 | 21.54K |
| Total | +20.80K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
41.60K shares
Shares
+41.60K
Strike price
8.10
Held after
41.60K
Exercisable
—
2/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock41.60K shares | 2/2/2026 | A · Award | +41.60K | 8.10 | — | 41.60K |